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ABSTRACT
Introduction: Policy- and evidence-based guidelines
have highlighted the need for improved palliative and
end-of-life care. However, there is still evidence of
individuals dying undignified deaths with little pain
control, therefore inflicting unnecessary suffering.
New commissioning powers have enabled a 2-year
pilot of an innovative integrated care pathway (ICP)
designed to improve arrangements for individuals with
life-limiting illnesses requiring palliative care. A novel
feature of the ICP is its focus on palliative care over the
last 6 months of life, aiming to intervene early to
prepare for and ensure a good death. What is not
known is if this pathway works, how it works and
who it works for.
Methods and analysis: A realist evaluation and
a complex analytical framework will investigate and
discover context, mechanism and outcome
conjectures and configurations of the ICP and thus
facilitate exploration of how it works and who it works
for. A mixed methods approach will be used with small
sample sizes to capture the breadth of the ICP. Phase 1
will identify if the pathway works through analysis of
NHS Morbidity Information Query and Export Syntax
data, locality Death Audit data and the Quality of Dying
and Death Questionnaire. Phase 2 employs soft
systems methodology with data from focus groups
with health professionals to identify how the pathway
works. Phase 3 uses the Miller Behavioural Style Scale
and interviews with palliative care patients and
bereaved relatives to analyse communication in
palliative care.
Ethics and dissemination: Ethical approval has
been granted from the NHS local ethics committee
(REC reference number: 11/NE/0318). Research &
Development approval has been gained from four
different trusts, and relevant voluntary organisations
and the local council have been informed about the
research. This protocol illustrates the complexity
inherent in evaluating a palliative care ICP.
Identification of whether the pathway works, how it
works and who it works for will be beneficial to all
practices and other care providers involved as it will
give objective data on the impact of the ICP. Results
will be disseminated throughout the study for
continuous quality improvement of the ICP. Outcomes
from each data collection phase will be disseminated
separately if analysis warrants it; all data collection will
be utilised in the realist evaluation. The research
provides a potential for the dissemination of the
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ARTICLE SUMMARY
Article focus
- This article is a protocol of a realist evaluation
of a palliative care ICP, which was developed in
Primary Care by health practitioners. The ICP itself
uses elements of long-term chronic illness care in
order to provide holistic, supportive, high-quality
palliative care. The focus of the article is to detail
how the ICP will be evaluated, using a variety of
data collection tools, which will identify contexts
and mechanisms that lead to improved outcomes,
thus taking the main focus away from just the
outcomes alone. The identification of contexts and
mechanisms for improved outcomes is known as
realist evaluation and will provide a better knowl-
edge of the essential conditions of effectiveness
when the ICP is implemented in other localities.
Key messages
- The key aim of this article is to detail the creation
of a complex realist evaluation, which utilises
a unique and varied methodological framework.
It is hoped that through this article, others will
understand the groundwork needed to set up and
execute a realist evaluation.
Strengths and limitations of this study
- The protocol details a complex evaluation of
a unique palliative care ICP using a new and
innovative methodology: realist evaluation.
- Some may perceive the small sample sizes in the
qualitative sections of the study as a weakness.
However, the aim of the study is not to find a robust
causal mechanism; this would be premature with
an ICP in its infancy. The aim is to unpack the
contexts and mechanisms that work in certain
circumstances, from this conditions crucial for
effectiveness can be highlighted, which are essen-
tial for implementation of the ICP in other localities.
- The ICP involves 15 general practitioner prac-
tices, which collectively care for 80 300 patients.
The study described will use Morbidity Informa-
tion Query and Export Syntax and Death Audit
data from all 15 practices and will conduct
the other sections of research within selected
practices, both rural and suburban.
- Finally, palliative care is commonly misunder-
stood in the literature and in the field. This paper
addresses this confusion and fills a gap in the
literature.
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pathway to other localities through the transferable knowledge it
will generate, from its focus on the contexts that are crucial for
successful implementation, the mechanisms that facilitate
implementation and the outcomes achieved.
BACKGROUND
End-of-life and palliative care are local, regional and
national priorities requiring continuous evaluation and
improvement. Policy and evidence-based guidelines
have identified a need for improved palliative and end-
of-life care services.1 2 However, there is still evidence
in the field, media and literature of individuals dying
undignified deaths with little pain control, therefore
inflicting unnecessary suffering on the patient and on
their relatives.3 4
In one semirural locality in the North East of England,
an innovative integrated care pathway (ICP) has been
created through use of new commissioning powers to
implement and continually improve arrangements for
individuals with life-limiting illnesses requiring palliative
care. The ICP, which has been in use since January 2010,
includes several interventions: palliative care registration,
Advance Care planning, a traffic light system of illness
progression, the ordering of just in case drugs and use
of the voluntary sector to fill gaps in care. The ICP
involves 15 general practitioner (GP) practices, which
collectively care for 80 300 patients. The project reported
here has been jointly funded by the NHS North of Tyne
in collaboration with Northumbria University and will
provide an opportunity to explore in detail the ways in
which the pathway works.
In the research literature, improvements in end-of-life
care through the use of ICPs have been noted.5 6 The
most researched and reported ICP related to end-of-life
care is the Liverpool Care Pathway (LCP)7; however, this
ICP focuses solely on the last few days of life as opposed
to palliative care for those with life-limiting illness. The
terms ‘palliative care’ and ‘end-of-life care’ are often
used interchangeably; this is confusing and makes the
generation of evidence difficult. In this research, the
term ‘palliative care’ is utilised in line with a palliative
diagnosis, which is given when an individual is presented
with a limited prognosis. Therefore, the disease can be
terminal at diagnosis, for example, those with advanced
prostate cancer, yet some individuals may be diagnosed
but live with well-managed symptoms for many years,
hence the intent is to treat as opposed to cure. The term
‘end-of-life care’ should be used in reference to the last
days and hours of life.8
While the prominent success of ICPs at the end of life
is clearly demonstrated in the literature,9e11 evidence of
the effectiveness of palliative care ICPs for those with life-
limiting illness is lacking. The ICP draws on principles
derived from many areas of healthcare including the
LCP and chronic disease management. However, little
is known about the transferability of evidence generated
in relation to the LCP and chronic disease management
to a palliative care ICP; therefore, these factors are key
parts of the study described here. There is also a lack
of understanding about the detailed way in which the
ICP may achieve success; information is needed on how
positive outcomes are attained and for whom they are
most beneficial. It would be premature to aim to estab-
lish linear cause and effect type relationships without
first attaining a better understanding of the conditions
for effectiveness. This ICP is complex, involving mul-
tiple organisations and a multidisciplinary style of work.
It therefore requires a novel methodological approach
to evaluation as described in this protocol.
Evaluation efforts for complex interventions are
unlikely to establish firm linear causal relationships.12
Taking a step away from seeking to find if a programme
‘works’ and moving towards highlighting the conditions
necessary for success is crucial in complex intervention
evaluation. The focus here is on the inner potential of
a system: the interventions, the mechanisms, the changes
in routine practice.13 Pawson and Tilley,14 the developers
of realistic evaluation, present an explanatory formula
which will be used throughout this study: outcome ¼
mechanism + context. This formula purports that new
initiatives’ final results (outcomes) are dependent on
the introduction of appropriate ideas and interventions
(mechanisms) and the appropriate existing social and
cultural condition (contexts). In metaphoric terms,
causality is attributed to the right substance being acti-
vated in the right conditions. A simple time A versus
time B comparison of data would not generate the
understanding that is required. Therefore, this research
aims to explore the inner potential of this palliative care
ICP for individuals with life-limiting illness through
context (C), mechanism (M) and outcome (O) conjec-
tures and developing configurations. For example, in
context A with mechanism B, outcome X is more prob-
able. An example of this is provided in an attempt to
modernise a health service15; in inner London (context),
integrating services across providers (mechanisms) led to
the patient having a seamless and consistent experience
(outcome). The study described here is deemed complex
according to the dimensions of complexity provided by
the Medical Research Council,12 which includes the
number of groups or organisational levels targeted and
number and variability of outcomes. In order to investi-
gate the ICP, a three-phase protocol was formulated,
which allows exploration of several realist evaluation
conjectures. Each Context Mechanism Outcome (CMO)
conjecture requires a different form of analysis thus
requiring the development of a multifaceted analytical
framework, as detailed in the remainder of the article.
AIMS, OBJECTIVES AND RESEARCH QUESTIONS
Study aim
The study will aim to systematically investigate key
features of contexts (GP practices, norms about palliative
care, relationships among organisations), mechanisms
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(communication, staff training, IT systems) and out-
comes (good death measure, reduced hospital admis-
sions, practitioner, patient and family satisfaction) and
their interactions in the ICP. It will identify and under-
stand the features of a comprehensive palliative ICP for
people with life-limiting illness.
Research question 1
Does the palliative care ICP work? Are the factors that
drive the palliative care ICP (Advanced Care Planning,
Palliative Care Register, Do Not Attempt Resuscitation
forms) all being utilised as intended? Does the ICP lead
to a good death in both the GPs’ and bereaved families’
experience?
Research question 2
What are the conditions of effectiveness of ICPs in
palliative care, in terms of implementation context and
intervention detaildfor whom does the ICP work, how
does it work and under what circumstances?
Research question 3
Who does the ICP work for? What are the patients’,
families’ and bereaved families’ experiences and opin-
ions of the ICP?
Research question 4
Can patients’ and health professionals’ respective coping
styles provide an explanatory framework for the research
evidence indicating that conversations about palliative
care are sometimes perceived as difficult?
Objectives
< To describe and develop an understanding of the
contexts surrounding ICP implementation and discover
how these contexts influence outcomes.
< To describe and develop an understanding of the
structure, organisation, interventions and general
implementation of the ICP (the mechanisms) and
therefore understand how the ICP works.
< To explore the perceptions of the ICP from those
involved including patients (palliative), staff (primary
and secondary care), carers and family and friends
of patients (mechanisms and outcomes).
< To investigate conversations about palliative care
between health professionals and patients, and the
effect of coping style (mechanisms and outcomes).
< To identify, describe and assess a range of outcomes
of the ICP.
Design
Putting realistic evaluation into practice
There are three phases to the research, undertaken
concurrently, within which the various CMO conjectures,
generated as a starting point for exploration and under-
standing following immersion in the field and literature,
are explored. It is believed that other CMO configura-
tions are likely to emerge from the investigation, and this
is embraced and accounted for by the research in terms
of its small participant numbers in all current sections
of data collection. This allows the research to be flexible
and responsive to emergent findings. This set up also
inherently acknowledges the sensitive nature of the re-
search and minimises research demands on participants.
Within the three research phases, several analytical
strategies will be utilised to make sense of the data (see
section on Analytical framework). By highlighting the
more beneficial contexts and mechanisms in different
areas of the ICP, progress can be made in both refining
and improving the ICP via feedback loops built into the
design. Additionally, information about optimal condi-
tions for implementation can be obtained, which will
be useful for implementation of the palliative care ICP
or any other similar health improvement initiatives, in
other areas of the country.
Analytical framework
The CMO conjectures referred to above will be investi-
gated using analytical frameworks, referred to as phase
maps (table 1). It is envisaged that outcomes from phase
maps 1 and 3 will feed into phase map 2. This is in order
to facilitate the initial focus group and to ensure that
a good breadth of data from several sources is continu-
ously fed back into subsequent focus groups. Table 1
details the type of participants in each section of
research and explicitly indicates which data collection
tools will be utilised, how data will be analysed and which
research question is being addressed.
Phase 1: does the palliative care ICP work?
MIQUEST and locality Death Audit data. Data collection:
Phase map 1 details the use of quantitative data available
from the 15 pilot sites in the form of the Death Audit
and Morbidity Information Query and Export Syntax
data. Both sets of data are routinely collected by prac-
tices: Death Audit data retrospectively since 2007 and
MIQUEST searches run routinely since 2009. While some
of the data overlaps, other data, such as that on Advance
Care plans and sudden deaths, do not.
Data analysis: Descriptive statistics will be generated
from the MIQUEST and Death Audit data.
The Quality of Dying and Death Questionnaire. Data collection:
There are several ‘good death’ measures available in
the literature; however, a recent systematic review found
the Quality of Dying and Death Questionnaire16 to be
the most widely studied and best validated.17 It will be
used to determine how many individuals who experi-
enced the ICP had a good death. This measure will be
distributed to bereaved families and key healthcare
workers involved in a patient’s care.
Data analysis: Descriptive comparison of perceptions.
Phase 2: what are the conditions of effectiveness of ICPs in
palliative care?
Data collection: Focus groups with health professionals
from many different backgrounds and services will be
carried out. This will include the ambulance service,
a hospice, GPs, community matrons, district nurses and
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social services. Three focus groups will be conducted
to allow an understanding of how the ICP works and
therefore lead to a model that will represent the real-
world ICP from practitioners’ viewpoints. Furthermore,
this model will help to highlight the contexts and mech-
anisms that are key to producing effective outcomes. It
is envisaged that these focus groups may also enhance the
ICP itself as they will provide practitioners with opportu-
nities to reflect on the ICP and summarised discussions
will be fed back. This will allow the research project to
build on practitioners’ combined organisational memory,
experience and wisdom.
Data analysis: Soft systems methodology (SSM) will be
the analytical framework for this section of research. It
is an epistemology that formulates carefully built models
of systems, which will be used to represent and analyse
the real-world situation. They will then be set against
perceptions of the real world by a process of comparison,
which will initiate debate leading to solutions of how
to improve the real-world situation through purposeful
action.18 SSM aims to provide assistance in coherently
expressing and operating the learning cycle from mean-
ings to intentions to relevant action without the rigidity
of a technique.18 19 SSM has been used to aid under-
standing in public health, outpatient services and chronic
disease management20e22; however, it has not yet been
used in the investigation of a palliative care ICP. The
use of focus groups will aid in the validation and devel-
opment of the SSM map and also help the ICP grow
and mature into a more efficient and effective initiative,
as in Tolson et al.23
Phase 3: who does the ICP work for?
Coping style. Data collection: A palliative diagnosis or
information about palliative care can both be classed as
distressing health-threatening information, which is diffi-
cult for the doctor to deliver and for the patient to
receive.24e26 The literature suggests conversations about
death occur infrequently and that this may be due to
professionals not feeling at ease with broaching the
subject.27e29 It is proposed that in such health-related
risk situations, individuals utilise distinctive attentional
processing styles, which allow them to be classified as
a high or low monitor.30 When faced with a health-
related risk, high monitors generally seek information,
magnify disease-related cues and display greater dissat-
isfaction about the amount of information provided.
Alternatively, blunters psychologically distract themselves
from health-related risk information and desire less
knowledge.
Table 1 Phase mapsdstudy participants, data collection and analyses for each research question
Major research
question
answered
Specific research
question answered
Participants
providing data Data source Data analysis
Phase
map 1
Does the
palliative care
ICP work?
Are the palliative care ICP
factors all being
conducted appropriately?
Palliative care
patients from one
of the practice sites
MIQUEST
data base/locality
Death Audit
Descriptive
statistics
Does the ICP lead to
a good death in both the
GPs and bereaved
families experience?
Relatives of
deceased palliative
care patients and the
health professionals
previously involved
in the patients
palliative care
Quality of Dying
and Death
Questionnaire
Descriptive
comparisons
Phase
map 2
What are the
conditions of
effectiveness
of ICPs in
palliative care?
In terms of implementation
context and intervention
detaildfor whom does
the ICP work, how does
it work and under what
circumstances?
Health professionals
involved with the ICP
Focus groups Soft systems
methodology
Phase
map 3
Who does the
ICP work for?
What are the patients,
families and bereaved
families opinions and
experiences of the ICP?
Palliative care
patients and their
families and bereaved
families of palliative
care patients
Interviews Interpretive
phenomenological
analysis
Palliative care
patients and
their GPs
Coping Style
Questionnaire
Classified
as monitor
or blunter
Voice recording
of consultations
Interpretive
phenomenological
analysis
GPs, general practitioners; ICP, integrated care pathway.
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The proposed use of coping style classification in this
project will be to investigate whether matched coping
styles between patients and health professionals offer
any explanatory potential for outcomes achieved. For
example, if a monitor health professional and a monitor
patient (classified through use of the Miller Behavioural
Style Scale)30 have a consultation, it is hypothesised that
their conversation about death will have a more positive
outcome than a conversation between a monitor health
professional and blunter patient. Individuals will be
classified as monitors or blunters, and following from
this, recordings of conversations/consultations about
palliative care will be made.
Data analysis: The questionnaire data will be analysed
by classifying individuals as monitors or blunters. The
audio recording of the consultation will be analysed
using thematic analysis. It is acknowledged that palliative
care conversations take place over time. Therefore, GPs
will have the opportunity to record up to three consul-
tations with one patient, if they believe that this is
necessary.
Interviews with palliative patients and bereaved family members.
Data collection: Semi-structured interviews will be
conducted with palliative care patients, their families
and friends, and bereaved families and friends of palli-
ative care patients. This provides rich in-depth qualita-
tive data about the ICP, whether it is working for patients
and family of patients and if it contributes to a good
death. It is also envisaged that information from these
interviews will feed back (anonymously) into the focus
groups with the healthcare professionals in order to
facilitate SSM modelling.
Data analysis: The transcripts of the interviews will be
analysed using IPA.31
Participants
In order to fulfil the research aims, the study will recruit
GPs, nurses, charity staff from local organisations, the
ambulance service, community matrons, social service
staff, palliative care patients, bereaved family members,
and friends and carers of palliative care patients.
In each different CMO conjecture, a different practice
will be selected for data collection, from the 15 practice
sites. This will avoid over burdening health professionals,
palliative care participants and bereaved family, friends
and carers of palliative care patients. The three practices
selected are rural, semirural and urban. Palliative care
participants will be selected via a GP screening method
to ensure no one is contacted who is suffering from
cognitive deficits or severe psychological distress. Palli-
ative care patients and bereaved family members,
friends and carers will be invited to participate in the
study via letter. Health professionals will be invited via
email or letter.
ETHICS AND DISSEMINATION
Research suggests that ICPs in end-of-life care are
successful,5e7 and therefore, a similar approach to the
palliative care of those with life-limiting illness may
be beneficial to staff, patients and families. However,
examination of syntheses of this research indicates that
currently the literature in this area is sparse. This study
is part of a PhD thesis that aims to elucidate if the new
ICP works and, if so, how it works and who it works
for. Several outcomes are anticipated from the study,
including: trends in quantitative measures from MIQUEST
data and locality Death Audit data, qualitative infor-
mation from the interviews, focus groups and Quality
of Dying and Death Questionnaire, SSM models of the
ICP and innovative information on coping style and
communication in palliative care. These outcomes will
allow the generation of knowledge about the key op-
erational factors that make the ICP a success and how
these are influenced by delivery context. Additionally,
this study will generate knowledge about the ICP that
will improve it via feedback while the research takes
place and will provide information to aid implementation
of the ICP in other geographical areas.
The study will also highlight gaps in knowledge about
palliative care and therefore the development of novel
forms of care may be created and implemented as
a result. This new knowledge could be utilised by a wide
spectrum of organisations and individuals working in this
area including new clinical commissioning consortia,
GP practices, acute hospital trusts, specialist palliative
care services, social care, community services, registered
charities, educationalists, patient advocates, and policy
makers to guide ICP implementation, service delivery and
service improvement. Currently, there is a vast amount
of policy and little practical implementation12; this study
may aid in implementing a long-term change in the GP
practice sites.
The ICP has been implemented since January 2010
in one locality of Northumberland involving 15 GP
practices serving 80 300 patients. A 1-year data collection
phase commenced in March 2012. The use of qualitative
and quantitative data means that there will be a consid-
erable amount of data generated with a wide range of
outcomes. The quantitative MIQUEST and Death Audit
data from the 15 GP practices involved with the ICP,
and study dates back from 2009 to 2007, respectively, and
includes many outcomes; therefore, it yields a consider-
able amount of information about various outcomes
over a substantial period of time.
Ethics
The conduct of the study will conform to relevant ethical
and legal guidelines covering informed consent, confi-
dentiality and data storage. Ethical approval was obtained
from the LREC through use of the Integrated Research
Application System on 12 January 2012. Research and
Development approval was gained from four different
NHS trusts due to the various participant groups in this
study. The voluntary sector and the council were also
informed of the study, and permission has been gained
to invite their staff to participate in the study where
appropriate.
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Dissemination
This study is large scale and will form a PhD thesis and
will be available in hard copy in Northumbria University
library and via the university’s online repository once
completed. As data collection occurs, platform presenta-
tions will be given and academic posters will be displayed
at relevant conferences. Additionally, publications will
be drafted; therefore, each section of data collection has a
potential for publication. Potential publications include
mapping of focus group’s discussions surrounding the
palliative care ICP; analysis of bereaved family members’
experience of terminal care and caring for a loved one; an
IPA of patient’s experience of palliative care; a statistical
review of MIQUEST and Death Audit data; results from
a matched health professional and bereaved relative
Quality of Death and Dying Questionnaire; coping
style and palliative care relationships and their effect on
consultations. All data that are collected will be utilised
in the realist evaluation, and publications are also
expected from this analysis. The results from the study
will also be fed back to the locality as they are analysed in
order to aid continuous quality improvement.
Steering group
This research has a dedicated steering group, which
aims to monitor progress of the study, address gover-
nance and ethical issues and overcome barriers in access
and resources. The steering group includes experienced
researchers from Northumbria University, a GP with
expertise in palliative care, a service user, a palliative care
Masters programme leader from Northumbria University
and a Research & Development lead representing the NHS
study sponsor. This steering group has been important
in both setting up the project and achieving milestones
such as LREC and Research & Development approval.
Conclusions
A novel and complex approach to practice has been
matched with a novel and complex evaluation method-
ology. While much of the learning generated by this
research will be on palliative care processes, there will
also be key methodological messages about developing
CMO conjectures early in a project and populating them
with evidence.
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